Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine
Due: June 6, 2025 This FOA provides support using the SBIR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated Read More